Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford ...

Germany’s Boehringer Ingelheim has selected a third drug candidate to move forward into IND-enabling studies under its ongoing collaboration with Oxford BioTherapeutics.

Canada's Foot-and-Mouth Disease vaccine bank is closer with new supply contracts, enhancing livestock protection and safeguarding trade.

Boehringer Ingelheim has breathed life into an American Lung Association campaign, providing support for a new push to educate people with bronchiectasis about how to better manage the disease.

TOKYO -- German drugmaker Boehringer Ingelheim plans to invest a total of 300 million euros ($346 million) in its plant in Japan from 2023 to 2028 as it moves to make the facility a production base ...

The site was created by Boehringer Ingelheim after a survey identified knowledge gaps among owners on many health topics ...

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

What happens when data projects forget the people who use them? A Disconnect. Boehringer Ingelheim turned things around by ...